key: cord-0759198-50yjpoi1
authors: Dinh, Aurélien; Dahmane, Lotfi; Dahoumane, Mehdi; Masingue, Xavier; Jourdain, Patrick; Lescure, François-Xavier
title: Impact of Omicron surge in community setting in greater Paris area
date: 2022-02-16
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2022.02.015
sha: 2bb5a46f9f7132738d20b8870d3b9f1e69a76237
doc_id: 759198
cord_uid: 50yjpoi1

nan

The SARS-CoV-2 Omicron variant of concern (VOC) was first identified in South Africa during November 2021, and has now become the dominant variant in Europe and worldwide.

However, as the number of Omicron COVID-19 cases increased rapidly in South Africa, the rate of hospitalization due to Omicron infections seemed lower than that of Delta infections [1] . However, a report by the Imperial College London found no evidence of lower rate of hospitalizations from Omicron infections than from Delta infections in England We aimed to assess the impact and clinical severity of patients infected during the Omicron surge compared with the previous surges in a large community setting in France.

We performed a cohort study including adult patients, with confirmed COVID-19 diagnosis (RT-PCR or antigen), managed from 9 March 2020 until 11 January 2022 with Covidom, a telesurveillance solution for home monitoring of patients with COVID-19 in the greater Paris area [3] . When included by a physician or after a positive test, the patients completed, on a daily basis, self-administered questionnaires on symptoms until 10 to 30 days according to symptom course. According to predefined thresholds, questionnaires could generate 2 types of alerts: orange alert (mild priority: heart rate 100-120 bpm, respiratory rate: 20-30/min, fever 38-40°C, mild dyspnea, digestive disorders), and red alert (suggest that the patient's condition may be deteriorating, they are top priority alert: heart rate>120bpm, respiratory rate>30/min, fever>40°C, severe dyspnea, major chest pain). The characteristics of patients were presented with frequencies and percentages for qualitative variables and mean ± standard deviation for quantitative variables. Correlations between surges were determined by chi-square test for categorical variables and 1-way ANOVA analysis for continuous variables. A P-value < 0.05 was considered statistically significant in all analyses. Analyses were performed with the use of R software, version 3.6.1 (R Foundation for Statistical Computing).

Overall, a total of 225,248 patients were included in the study, including 72,394 from the last surge, which is more numerous compared to the previous surges. The characteristics of the study patients depending on the surge are presented in Table 1 .

Patients included during the Delta and Omicron waves were younger (mean age 35.6 ± 13.0 and 38.4 ± 13.0 versus maximum 44.5 ± 14.5 years in surge 1; p<0.001).

Significantly fewer patients with comorbidities were included in surge 5 (p<0.001), and the proportion presenting with respiratory signs was lower (49.8% in surge 5 vs maximum 86.5% in surge 1; p<0.001). During surge 5, while the number of patients included was high compared to previous surges, the rate of orange and red alerts was significantly lower (p<0.0001), as the number of hospitalizations, national emergency contact and emergency unit requirement (p<0.0001).

Of the 15,376 patients included in surge 5 who responded regarding their vaccination status, 73.7% were completely vaccinated (at least 2 doses, with or without booster shot), 2.7% were partially vaccinated (only one dose without previous history of COVID-19), and 23.6%

were unvaccinated.

In our study, a huge increase of COVID cases were registered from the 1 st of December 2021 to the 11 th of January 2022, compared to previous surges.

However, the proportion of risk factors are lower, as well as the rate of red alerts, hospitalizations, or Emergency contacts.

These data confirm that the Omicron surge is highly significant considering the number of cases but presents with a low rate of severe presentation and worsening.

The main limit of this study is due to its retrospective design with non-exhaustive data.

Furthermore, patients' profile between surges could differ due to several factors. Indeed, the level of immunity after four previous surges and high vaccination rates worldwide should be taken into account, as it may partially explain the lower severity during the Omicron surge.

Also, the Omicron variant seems to be better able to infect people with preexisting immunity (because of vaccination or a previous infection) than previous variants [4], although vaccines still remains effective against hospitalization.

Our study shows that the Omicron surge will probably impact strongly healthcare systems despite its low rate of severe cases.

This study was approved by the scientific and ethical committee of the Assistance Publique-Hôpitaux de Paris (IRB00011591).

All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. the first draft of the manuscript. All authors revised the manuscript and approved the final version. AD had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. J o u r n a l P r e -p r o o f 

Data are presented as n (%), unless otherwise stated. BMI: body mass index; SD: standard deviation

We thank the patients for granting permission to publish this information. We thank the Nouveal-e-Santé team for their help in the web application and regional centre surveillance interface development. We thank Clara Duran for her help in writing the manuscript.

AD, PJ, and FXL conceptualized the study. AD, LD, MD, and XM collected, analyzed, and interpreted the data. LD and MD conducted the statistical analysis. AD, LD, and FXL wrote